---
title: "Daily U.S. Stock Market News Briefing (November 29, Friday)"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/221033793.md"
description: "Daily news summary of the US stock market: ASML's AZD5462 new drug has received clinical trial approval, AstraZeneca's DS8201 drug has been included in the medical insurance catalog, BlackRock is close to acquiring HPS Investment Partners, Amazon is developing an AI video model, Microsoft is under FTC antitrust investigation, Vale announces dividends, Salesforce's online sales growth, Miniso's revenue growth in the first three quarters, Bilibili rises 2% due to Taobao live streaming, Google faces antitrust lawsuits in Canada, India notifies Volkswagen of tax evasion"
datetime: "2024-11-29T13:54:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/221033793.md)
  - [en](https://longbridge.com/en/news/221033793.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/221033793.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/221033793.md) | [English](https://longbridge.com/en/news/221033793.md)


# Daily U.S. Stock Market News Briefing (November 29, Friday)

Individual Stock News

1.  ASML (ASML.O) has received implied permission for clinical trials from the National Medical Products Administration for its Class 1 new drug AZD5462 tablets, which are intended for the treatment of heart failure.
    
2.  The 2024 National Medical Insurance Catalog shows that AstraZeneca (AZN.O) negotiated for the inclusion of the "breast cancer miracle drug" DS8201 injection of trastuzumab deruxtecan in the catalog. Previously, this drug failed to enter the 2023 medical insurance catalog after being listed for formal review in 2023.
    
3.  According to insiders, BlackRock (BLK.N) is close to reaching an agreement to acquire the private credit group HPS Investment Partners, with a final price approaching $12 billion.
    
4.  According to The Information, Amazon (AMZN.O) is developing video artificial intelligence models to hedge its reliance on Anthropic.
    
5.  Sources say that the U.S. Federal Trade Commission (FTC) has launched an antitrust investigation into Microsoft (MSFT.O), covering the company's cloud computing and software licensing business as well as cybersecurity and artificial intelligence products.
    
6.  Vale (VALE.N): The board has approved a dividend of approximately 0.52 Brazilian reais per share.
    
7.  Salesforce (CRM.N) reported on Thursday that online sales during the first half of the U.S. Thanksgiving holiday increased by about 4%, compared to just 2% growth in the same period last year.
    
8.  Miniso (MNSO.N): The company's revenue for the first three quarters reached 12.28 billion yuan, a year-on-year increase of 22.8%.
    
9.  Bilibili (BILI.O) rose 2% in pre-market trading, following news that Taobao's official account is live-streaming sales on Bilibili.
    
10.  The Canadian Competition Bureau has filed a lawsuit against Google (GOOG.O), accusing it of anti-competitive behavior in online advertising in Canada.
     
11.  India has reportedly issued a notice to Volkswagen, stating that it has evaded taxes

### 相關股票

- [AstraZeneca (AZN.US)](https://longbridge.com/zh-HK/quote/AZN.US.md)
- [ASML (ASML.US)](https://longbridge.com/zh-HK/quote/ASML.US.md)
- [Amazon (AMZN.US)](https://longbridge.com/zh-HK/quote/AMZN.US.md)

## 相關資訊與研究

- [AstraZeneca says Efzimfotase alfa PH3 program show positive results](https://longbridge.com/zh-HK/news/281138062.md)
- [K-Buddhism: "AI Sage", Can an AI awaken to its Original Nature? | AMZN Stock News](https://longbridge.com/zh-HK/news/281059138.md)
- [AstraZeneca reports positive data from Phase III trial of efzimfotase alfa](https://longbridge.com/zh-HK/news/281448174.md)
- [AstraZeneca drug reduces flare-ups of chronic lung disease in late-stage trials](https://longbridge.com/zh-HK/news/280802962.md)
- [ACC 2026: Baxdrostat lowers BP in uncontrolled hypertension](https://longbridge.com/zh-HK/news/281159879.md)